The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?
about
Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases.
P2860
The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The use of stereotactic radios ...... ast cancer: who benefits most?
@ast
The use of stereotactic radios ...... ast cancer: who benefits most?
@en
type
label
The use of stereotactic radios ...... ast cancer: who benefits most?
@ast
The use of stereotactic radios ...... ast cancer: who benefits most?
@en
prefLabel
The use of stereotactic radios ...... ast cancer: who benefits most?
@ast
The use of stereotactic radios ...... ast cancer: who benefits most?
@en
P2093
P2860
P1476
The use of stereotactic radios ...... ast cancer: who benefits most?
@en
P2093
Hannah M Linden
Jason K Rockhill
Lena Rubinstein
Lia M Halasz
Mark Philips
Michael F Gensheimer
Philip Stevenson
Ted Gooley
Vijayakrishna K Gadi
P2860
P2888
P304
P356
10.1007/S10549-014-3242-X
P407
P577
2015-02-01T00:00:00Z